Submitted by Anonymous (not verified) on 9 January 2026 - 14:30
Human medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation: 23/09/2015, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation: 23/09/2015, Revision: 26, Status: Authorised